Compliance issues: Use of modifiers 59, 91 for urine drug screens under scrutiny by OIG
A massive revision to drug screen codes and new local coverage determinations aren’t the only challenges pain management practices that perform drug screens must meet. Increased investigator activity is aimed at curbing abusive billing.
To read the full article, sign in and subscribe to the DecisionHealth Newsletters.